Showing results (671-680 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|January 22, 2022
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysisWillis S Bowman, Chad A Newton, Angela L Linderholm, et al.
The Lancet. Respiratory Medicine|February 6, 2022
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trialE Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, et al.
The Lancet. Respiratory Medicine|February 1, 2022
Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trialSteve Turner, Seonaidh Cotton, Jessica Wood, et al.
The Lancet. Respiratory Medicine|April 1, 2022
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 studyMichael E Wechsler, Andrew Menzies-Gow, Christopher E Brightling, et al.
The Lancet. Respiratory Medicine|April 15, 2022
Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorderMichael H Cho, Brian D Hobbs, Edwin K Silverman
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension studyGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trialPradeesh Sivapalan, Therese S Lapperre, Julie Janner, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Pragmatic methods to avoid intensive care unit admission when it does not align with patient and family goalsNita Khandelwal, Ann C Long, Robert Y Lee, et al.
The Lancet. Respiratory Medicine|May 25, 2019
Understanding irresponsible use of intensive care unit resources in the USAGeorge L Anesi, Andrew J Admon, Scott D Halpern, et al.
Pageof 104